Athelas

Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.

Description

Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.

Founded

2016

Employees

180

Last Funding

1/31/2022

Funding Round

Venture - Series Unknown

Total Funding

$150,131,620

Specialty focus

Target Customer Segments

Digital Health Provider; Ambulatory Practice

For companies that serve

Technical details

Key customers

Alternatives

Will sign BAA